USING THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) FOR TARGETED IMMUNOTHERAPY - ASSESSMENT OF THE PHARMACOKINETICS AND BIODISTRIBUTION OF 2 DIVALENT, RICIN-BASED ANTI-CCLLA IMMUNOTOXINS (ITS) IN XENOGRAFTED NUDE-MICE
Gb. Faguet et al., USING THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) FOR TARGETED IMMUNOTHERAPY - ASSESSMENT OF THE PHARMACOKINETICS AND BIODISTRIBUTION OF 2 DIVALENT, RICIN-BASED ANTI-CCLLA IMMUNOTOXINS (ITS) IN XENOGRAFTED NUDE-MICE, Blood, 86(10), 1995, pp. 3315-3315